Owen Wallace
Chief Tech/Sci/R&D Officer bij MONTE ROSA THERAPEUTICS, INC.
Vermogen: 37 125 $ op 31-03-2024
Profiel
Owen Wallace is currently the Chief Scientific Officer at Monte Rosa Therapeutics, Inc. Prior to this, he was the Chief Scientific Officer at Fulcrum Therapeutics, Inc. from 2017 to 2021.
He was also the Head-Global Discovery Chemistry at Novartis Institutes for Biomedical Research, Inc. from 2013 to 2017.
From 2002 to 2013, he worked at Eli Lilly & Co. as a Senior Director.
He also worked as a Senior Director-Discovery Chemistry Research at Lilly Research Centre Ltd.
He received his graduate and doctorate degrees from Yale University and his undergraduate degree from University College Cork.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-01-2024 | 5 266 ( 0.01% ) | 37 125 $ | 31-03-2024 |
Actieve functies van Owen Wallace
| Bedrijven | Functie | Begin |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-02-2021 |
Eerdere bekende functies van Owen Wallace
| Bedrijven | Functie | Einde |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05-02-2021 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-04-2017 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01-06-2013 |
| Lilly Research Centre Ltd. | Corporate Officer/Principal | - |
Opleiding van Owen Wallace
| Yale University | Doctorate Degree |
| University College Cork | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| Lilly Research Centre Ltd. | |
| Monte Rosa Therapeutics, Inc. |
